Pharmacogenomics (PGx) provides insights into how genetics affect drug responses. However, short-read panels can struggle to decipher the full depth of the genome. Long-read sequencing can measure full genes from end to end, providing critical information on phasing, repeats, copy number variants, and structural context.
Download this case study to explore how a 49-gene, long-read PGx panel yields faster, cleaner, and more interpretable pharmacokinetic and pharmacodynamic readouts.
